M. Arai

发表

Arborcandins A, B, C, D, E and F, novel 1,3-beta-glucan synthase inhibitors: production and biological activity.

Y. Kurihara, S. Miyakoshi, M. Inukai, 2000, The Journal of antibiotics.

Mechanism of action of globomycin.

M. Inukai, M. Takeuchi, M. Arai, 1978, The Journal of antibiotics.

A-72363 A-1, A-2, and C, novel heparanase inhibitors from Streptomyces nobilis SANK 60192, II. Biological activities.

K. Tanzawa, T. Takatsu, M. Nakajima, 1996, The Journal of antibiotics.

Globomycin sensitivity of Escherichia coli and Salmonella typhimurium: effects of mutations affecting structures of murein lipoprotein

W. Philbrick, Y. Hirota, M. Inukai, 1981, Journal of bacteriology.

Existence of the bound form of prolipoprotein in Escherichia coli B cells treated with globomycin

M. Inukai, M. Takeuchi, M. Arai, 1979, Journal of bacteriology.

Studies on Novel Bacterial Translocase I Inhibitors, A-500359s

Yasunori Muramatsu, Y. Sakaida, S. Miyakoshi, 2006, The Journal of Antibiotics.

Isolation of three main components. F3, F4 and F5, from azalomycin F-complex.

K. Hamano, M. Arai, 1970, The Journal of antibiotics.

Studies on novel bacterial translocase I inhibitors, A-500359s. I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation of A-500359 A, C, D and G.

T. Ohnuki, Yasunori Muramatsu, T. Takatsu, 2003, The Journal of antibiotics.

Studies on novel bacterial translocase I inhibitors, A-500359s. III. Deaminocaprolactam derivatives of capuramycin: A-500359 E, F, H; M-1 and M-2.

T. Ohnuki, Yasunori Muramatsu, T. Takatsu, 2003, The Journal of antibiotics.